Semmax Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Semmax Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1	Closed	–	–	290
2021 Q4	$0	Hold	1	–	–	﹤0.01%	273
2021 Q3	$0	Hold	1	–	–	﹤0.01%	265
2021 Q2	$0	Hold	1	–	–	﹤0.01%	270
2021 Q1	$0	Hold	1	–	–	﹤0.01%	274
2020 Q4	$0	Hold	1	–	–	﹤0.01%	257
2020 Q3	$0	Hold	1	–	–	﹤0.01%	261
2020 Q2	$0	Hold	1	–	–	﹤0.01%	278
2020 Q1	$0	Hold	1	–	–	﹤0.01%	285
2019 Q4	$0	Hold	1	–	–	﹤0.01%	285
2019 Q3	$0	Sell	1 -23	-96%	-$2.41K	﹤0.01%	308
2019 Q2	$3K	Sell	24 -805	-97%	-$85.6K	﹤0.01%	254
2019 Q1	$93K	Sell	829 -267	-24%	-$29.3K	0.06%	169
2018 Q4	$106K	Buy	+1,096	New	+$116K	0.08%	152

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Semmax Financial Advisors's IBB Position: Q1 2022 in Review

Semmax Financial Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1 share.

Semmax Financial Advisors first reported a position in IBB in Q4 2018 and held it in 13 quarters. The position peaked at $106K in Q4 2018. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Semmax Financial Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Semmax Financial Advisors sold 1 iShares Biotechnology ETF share in Q1 2022.
Semmax Financial Advisors first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 13 quarters.
Semmax Financial Advisors's iShares Biotechnology ETF position peaked at $106K in Q4 2018.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Semmax Financial Advisors's 13F filing for Q1 2022, filed 11 May 2022.